Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Sir Gordon Duff has been awarded an Honorary Senior Fellowship at NDORMS.

Sir Gordon Duff

The former Principal of St Hilda's College, Oxford, and University Pro-Vice Chancellor, joined NDORMS in July 2021 with a focus on translational medicine and the development of modern therapeutics.

Sir Gordon was past-Chair of BBSRC, SAGE and MHRA and is now dedicated to improving human health through planetary health. He played a pivotal role in the appointment of Oxford's first Climax Chair of Clinical Therapeutics, Professor Duncan Richards, and in the University's plans to establish a new Oxford Experimental Medicine Clinical Research Facility (Oxford EMCRF) within NDORMS.

Commenting on his Fellowship Sir Gordon said: "I feel privileged with this honorary appointment in NDORMS, one of the leading Departments in any Medical School worldwide, and look forward to contributing what I can to the continued success of NDORMS in pioneering health advances."

Head of Department Professor Andrew Carr said; "It is a great pleasure to welcome Sir Gordon as a Senior Research Fellow in NDORMS. He has a long association with the department and his knowledge and insights will provide a considerable boost to many of our activities."

Similar stories

Could patients with common fractures recover without routine hospital follow-up?

The FASTER study will investigate whether thousands of people with common fractures can recover just as well with good-quality advice and rehabilitation guidance, without the need for routine hospital follow-up appointments.

Could the gut’s nervous system hold new clues to treating Crohn’s disease?

Researchers at the Kennedy Institute are investigating whether the nervous system within the gut could provide a new way to understand and ultimately treat Crohn’s disease.

NDORMS appoints a new Research Professor of Regulatory Innovation to help accelerate the development pipeline of new treatments

Lincoln Tsang has been appointed as the new John Climax Research Professor of Regulatory Innovation – a new role at NDORMS and the University of Oxford that brings global regulatory and legal expertise to our ambitions to transform and improve drug development pathways in order to help deliver safe and effective treatments to patients sooner. He will assume this role effective 2 January 2027.

Look Beyond My Skin: Your Psoriasis Could Help Us Understand Who Develops Psoriatic Arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.

New PI Marie Pust aims to bring microbiome research closer to patients

We welcome Marie-Madlen Pust, who has joined the Kennedy Institute as a new Principal Investigator. Marie will establish a research group combining computational biology with targeted experimental microbiology to identify microbial drivers of chronic inflammatory disease that can be monitored (diagnostic potential) or modified (therapeutic potential).

Oxford EMCRF starts pioneering engineered nTreg trial for severe autoimmune disease

The Oxford Experimental Medicine Clinical Research Facility (EMCRF) has recruited its first patients into the CHILL trial, an early-phase study of an innovative cell therapy for severe autoimmune disease.